GISSI

	WikiDoc Resources for GISSI
Articles
Most recent articles on GISSI Most cited articles on GISSI Review articles on GISSI Articles on GISSI in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on GISSI Images of GISSI Photos of GISSI Podcasts & MP3s on GISSI Videos on GISSI
Evidence Based Medicine
Cochrane Collaboration on GISSI Bandolier on GISSI TRIP on GISSI
Clinical Trials
Ongoing Trials on GISSI at Clinical Trials.gov Trial results on GISSI Clinical Trials on GISSI at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on GISSI NICE Guidance on GISSI NHS PRODIGY Guidance FDA on GISSI CDC on GISSI
Books
Books on GISSI
News
GISSI in the news Be alerted to news on GISSI News trends on GISSI
Commentary
Blogs on GISSI
Definitions
Definitions of GISSI
Patient Resources / Community
Patient resources on GISSI Discussion groups on GISSI Patient Handouts on GISSI Directions to Hospitals Treating GISSI Risk calculators and risk factors for GISSI
Healthcare Provider Resources
Symptoms of GISSI Causes & Risk Factors for GISSI Diagnostic studies for GISSI Treatment of GISSI
Continuing Medical Education (CME)
CME Programs on GISSI
International
GISSI en Espanol GISSI en Francais
Business
GISSI in the Marketplace Patents on GISSI
Experimental / Informatics
List of terms related to GISSI

The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) (Italian group for the study of the survival of Myocardial Infarction) is an influential cardiology research group founded as a collaboration between two Italian organisations – the Mario Negri Institute and the Associazione Nazionale dei Medici Cardiologi Ospedalieri (ANMCO).^[1] The trials carried out by GISSI have "obtained wide recognition in the international world of cardiology and are considered a methodological landmark"^[1]. Four large-scale clinical trials over the past 20 years (GISSI 1^[2]^[3], GISSI 2^[4]^[5], GISSI 3^[6], GISSI Prevention^[7]) have involved more than 60,000 patients with acute myocardial infarction (AMI).^[1]

References

↑ ^1.0 ^1.1 ^1.2 http://www.gissi.org/EngIntro/T_Intro_ENG.php
↑ "Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)". Lancet. 1 (8478): 397–402. 1986. PMID 2868337.
↑ "Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico (GISSI)". Lancet. 2 (8564): 871–4. 1987. PMID 2889079.
↑ "GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico". Lancet. 336 (8707): 65–71. 1990. PMID 1975321.
↑ "In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group". Lancet. 336 (8707): 71–5. 1990. PMID 1975322.
↑ "GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico". Lancet. 343 (8906): 1115–22. 1994. PMID 7910229.
↑ "Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico". Lancet. 354 (9177): 447–55. 1999. PMID 10465168.

GISSI

References

Further reading

Navigation menu